home / stock / bdr / bdr news


BDR News and Press, Blonder Tongue Laboratories Inc. From 05/07/19

Stock Information

Company Name: Blonder Tongue Laboratories Inc.
Stock Symbol: BDR
Market: NYSE
Website: blondertongue.com

Menu

BDR BDR Quote BDR Short BDR News BDR Articles BDR Message Board
Get BDR Alerts

News, Short Squeeze, Breakout and More Instantly...

BDR - Blonder Tongue Schedules Conference Call to Discuss First Quarter 2019 Earnings Results

OLD BRIDGE, NJ / ACCESSWIRE / May 7, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it will report its First Quarter 2019 Earnings Results on Wednesday, May 15, 2019 prior to market opening. Management will then host a teleconference to discuss the resul...

BDR - Blonder Tongue Announces New ATSC3Pro(TM) Suite of Broadcast and Development Tools at NAB Show 2019

LAS VEGAS, NV and OLD BRIDGE, NJ / ACCESSWIRE / April 8, 2019 / Blonder Tongue Laboratories, Inc . (NYSE American: BDR) announces the availability of their new ATSC3pro™ Suite of Broadcast compliance and development tools at the National Association of Broadcasters yearly conventio...

BDR - Blonder Tongue Laboratories, Inc. (BDR) CEO Robert Palle on Q4 2018 Results - Earnings Call Transcript

Blonder Tongue Laboratories, Inc. (BDR) Q4 2018 Results Conference Call April 01, 2019 11:00 AM ET Company Participants Robert Palle - President and Chief Executive Officer Ted Grauch - Chief Operating Officer Eric Skolnik - Chief Financial Officer Presentation [Call Starte...

BDR - Blonder Tongue Laboratories reports Q4 results

Blonder Tongue Laboratories (NYSEMKT: BDR ): Q4 GAAP EPS of -$0.08. More news on: Blonder Tongue Laboratories, Inc., Earnings news and commentary, Tech stocks news, , Read more ...

BDR - Blonder Tongue Reports Fourth Quarter and Year End 2018 Results

OLD BRIDGE, NJ / ACCESSWIRE / April 1, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR ) announced its sales and results for the fourth quarter and year ended December 31, 2018. Net sales decreased $129,000 or 2.3% to $5,441,000 for the fourth quarter of 2018 from $5,570,0...

BDR - Blonder Tongue Schedules Conference Call to Discuss Fourth Quarter and Year End 2018 Earnings Results

OLD BRIDGE, NJ / ACCESSWIRE / March 25, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced today that it will report its Fourth Quarter 2018 Earnings Results on Monday, April 1, 2019 prior to market opening. Management will then host a teleconference to discuss the res...

BDR - Blonder Tongue Announces Date of 2019 Annual Meeting of Stockholders

OLD BRIDGE, NJ / ACCESSWIRE / March 4, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced that its 2019 Annual Meeting of Stockholders will be held at 10:00 a.m. on Thursday, May 30, 2019, at the Company's headquarters located at One Jake Brown Road, Old Bridge, New Je...

BDR - Blonder Tongue Labs Announces the Release of New Advanced Capabilities for its NXG Video Management Platform at the NCTC Winter Education Conference 2019

ATLANTA, GA and OLD BRIDGE, NJ / ACCESSWIRE / February 25, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) is proud to announce the release of Geographically Localized Emergency Alert (Geo-EAS) insertion, Clear QAM, high density IP ingest, and local EPG insertion capability s...

BDR - Blonder Tongue Labs to Provide Kaon MOBITV - Android TV Set-Top Box Sales, Marketing, Personalization and Fulfillment for US and Canadian Service Operators

OLD BRIDGE, NJ / ACCESSWIRE / February 25, 2019 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) is proud to announce the immediate availability of the Kaon line of Android TV Set-Top Box products specifically designed and optimized for MOBITV platform deployments across North Amer...

BDR - STI, ATOS among premarket gainers

Atossa Genetics (NASDAQ: ATOS ) +29%  on updating the status of the pre-menopausal, estrogen-receptor positive (ER+) breast cancer patient who received preoperative oral Endoxifen therapy under an FDA-approved “expanded access” program. More news on: Atossa Genetics, ...

Previous 10 Next 10